Last Updated: May 11, 2026

Suppliers and packagers for BUPIVACAINE LIPOSOME


✉ Email this page to a colleague

« Back to Dashboard


BUPIVACAINE LIPOSOME

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Hengrui Pharma BUPIVACAINE LIPOSOME bupivacaine INJECTABLE, LIPOSOMAL;INJECTION 214348 ANDA Jiangsu Hengrui Pharmaceuticals Co., Ltd. 57884-3251-1 10 VIAL in 1 CARTON (57884-3251-1) / 10 mL in 1 VIAL 2024-07-01
Hengrui Pharma BUPIVACAINE LIPOSOME bupivacaine INJECTABLE, LIPOSOMAL;INJECTION 214348 ANDA Jiangsu Hengrui Pharmaceuticals Co., Ltd. 57884-3252-1 10 VIAL in 1 CARTON (57884-3252-1) / 20 mL in 1 VIAL 2024-07-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

BUPIVACAINE LIPOSOME: What Suppliers Provide the Product or Core Inputs?

Last updated: April 28, 2026

Which companies supply bupivacaine liposome products used in clinical or commercial settings?

Bupivacaine liposome is a formulation category that appears in branded products and, separately, as components used by developers. The supplier landscape splits into two buckets:

1) Branded, market-facing manufacturers (product suppliers) 2) Upstream suppliers of enabling inputs (lipid components, manufacturing services, and contract development and manufacturing organizations)

This response covers product suppliers only where the supplier identity is clearly tied to a specific bupivacaine liposome product name.

Product supplier map (branded bupivacaine liposome)

Bupivacaine liposome product (common reference) Supplier / manufacturer Role in supply chain
EXPAREL (bupivacaine liposome injectable suspension) Pacira BioSciences, Inc. Product manufacturer / marketing authorization holder in the US

Source: Pacira product information for EXPAREL (bupivacaine liposome injectable suspension). [1]

Are there multiple “bupivacaine liposome” suppliers beyond EXPAREL?

A second supplier identity depends on whether the request targets:

  • Exact branded products (where the supplier is a legal entity tied to that product), or
  • Unbranded “bupivacaine liposome” APIs or excipient systems (where suppliers differ by lipid composition and contract manufacturing arrangement).

No additional branded “bupivacaine liposome” supplier names are provided in the available basis used here beyond the EXPAREL manufacturer above. [1]

What counts as “supplier” for bupivacaine liposome procurement?

In procurement and due diligence, “supplier” usually means one of these:

  • Finished dosage form supplier (injectable suspension in labeled packaging)
  • Marketing authorization holder / product manufacturer (entity responsible for commercial release)
  • Contract development and manufacturing organization (CDMO) (entity producing under contract)
  • Material suppliers (key lipids, buffers, and fill-finish consumables)

For decision-making tied to patient access or contracting, the most direct supplier in this formulation category is the finished product manufacturer for the named branded product.

What is the single most direct product supplier for bupivacaine liposome procurement in the US?

Pacira BioSciences, Inc.

Company Product Procurement implication
Pacira BioSciences, Inc. EXPAREL (bupivacaine liposome injectable suspension) Direct commercial product supply for the branded bupivacaine liposome product

Source: EXPAREL prescribing information lists Pacira BioSciences, Inc. as the manufacturer. [1]

What suppliers provide the core bupivacaine liposome system (lipids, manufacturing inputs)?

The supplier set for lipid components and contract manufacturing services is formulation-specific and depends on the exact liposome composition and manufacturing process used by a given product. The supplier list is not determinable from the cited basis used here because no supplier names for lipid ingredients or CDMO/manufacturing inputs are provided in the available references.

How to structure supplier outreach for bupivacaine liposome in practice

Use a two-track procurement plan:

  • Track 1: Finished product (contract with product manufacturer or authorized distributor)
    • Target: Pacira BioSciences, Inc. for EXPAREL in the US context. [1]
  • Track 2: Development-grade supply (for investigational or generic/formulation work)
    • Target: CDMOs and lipid suppliers chosen based on the exact formulation and process requirements.

Only Track 1 is explicitly supported by supplier identity in the available source basis.


Key Takeaways

  • Pacira BioSciences, Inc. is the identified product supplier/manufacturer for EXPAREL (bupivacaine liposome injectable suspension). [1]
  • Additional “bupivacaine liposome” suppliers can exist for investigational formulations or non-branded ingredient systems, but they are not named in the cited basis used here.

FAQs

1) Who manufactures EXPAREL (bupivacaine liposome)?
Pacira BioSciences, Inc. [1]

2) Is Pacira the supplier for all bupivacaine liposome products?
The identified supplier in the cited basis is tied to EXPAREL. [1]

3) Do bupivacaine liposome suppliers include CDMOs?
Yes in principle, but specific CDMO supplier names are not provided in the cited basis used here.

4) What is the most direct supplier route for bupivacaine liposome in the US?
Contract with the EXPAREL product manufacturer or its authorized channels, where the manufacturer is Pacira BioSciences, Inc. [1]

5) What supplier category matters most for contracting at hospitals or IDNs?
The finished product supplier for the labeled injectable suspension (for EXPAREL, Pacira). [1]


References

[1] Pacira BioSciences, Inc. EXPAREL (bupivacaine liposome injectable suspension) Prescribing Information.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.